AR090580A1 - PHARMACEUTICAL COMPOSITIONS FOR COMBINED THERAPY - Google Patents

PHARMACEUTICAL COMPOSITIONS FOR COMBINED THERAPY

Info

Publication number
AR090580A1
AR090580A1 ARP130101075A AR090580A1 AR 090580 A1 AR090580 A1 AR 090580A1 AR P130101075 A ARP130101075 A AR P130101075A AR 090580 A1 AR090580 A1 AR 090580A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical compositions
tetrabenazine
combined therapy
movement disorders
pridopidine
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Susanna Holm Waters Eva
Nicholas Waters Ross
Original Assignee
Ivax Int Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivax Int Gmbh filed Critical Ivax Int Gmbh
Publication of AR090580A1 publication Critical patent/AR090580A1/en

Links

Abstract

Composiciones farmacéuticas que comprenden una combinación terapéuticamente eficaz de un estabilizador dopaminérgico conocido como pridopidina, y un inhibidor del transportador vesicular de monoamina tipo 2 (VMAT) conocido como tetrabenazina. Las composiciones farmacéuticas son útiles para mejorar los efectos terapéuticos sintomáticos, y para reducir los efectos adversos, de tetrabenazina en el tratamiento de los trastornos de movimiento, y en particular los trastornos de movimiento asociados con la enfermedad de Huntington, síndrome de Gilles de la Tourette, o disquinesia tardía.Pharmaceutical compositions comprising a therapeutically effective combination of a dopamine stabilizer known as pridopidine, and an inhibitor of the vesicular monoamine transporter type 2 (VMAT) known as tetrabenazine. The pharmaceutical compositions are useful for improving symptomatic therapeutic effects, and for reducing the adverse effects, of tetrabenazine in the treatment of movement disorders, and in particular movement disorders associated with Huntington's disease, Gilles de la Tourette syndrome , or tardive dyskinesia.

ARP130101075 2012-04-04 2013-04-03 PHARMACEUTICAL COMPOSITIONS FOR COMBINED THERAPY AR090580A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261620203P 2012-04-04 2012-04-04
US201261625192P 2012-04-17 2012-04-17

Publications (1)

Publication Number Publication Date
AR090580A1 true AR090580A1 (en) 2014-11-19

Family

ID=49773120

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130101075 AR090580A1 (en) 2012-04-04 2013-04-03 PHARMACEUTICAL COMPOSITIONS FOR COMBINED THERAPY

Country Status (3)

Country Link
AR (1) AR090580A1 (en)
TW (1) TW201345528A (en)
UY (1) UY34728A (en)

Also Published As

Publication number Publication date
TW201345528A (en) 2013-11-16
UY34728A (en) 2013-10-31

Similar Documents

Publication Publication Date Title
CO2020003478A2 (en) Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1) inhibitors and their uses
CO2017004525A2 (en) Ror-gamma inhibitory dihydropyrrolopyridines
BR112014024672A8 (en) PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY
CO2018012482A2 (en) Formulations of an lsd1 inhibitor
DOP2019000005A (en) 3-METIL PIRAZINAS 2,5-DISUSTITUIDAS AND 3-METIL PIRAZINAS 2,5,6-TRISUSTITUIDAS AS ALLOSTERIC INHIBITORS OF SHP2
CO2019007810A2 (en) Amino-triazolopyridine compounds and their use in the treatment of cancer
MX2020004467A (en) Methods for treating or preventing asthma by administering an il-4r antagonist.
SV2015005115A (en) DERIVATIVES OF PIRAZOLOPIRROLIDINE AND ITS USE IN THE TREATMENT OF DISEASES
CR20160518A (en) COMPOUNDS TO TREAT SPINAL MUSCLE ATROPHY
AR107871A1 (en) COMBINATIONS OF LSD1 INHIBITORS FOR USE IN THE TREATMENT OF SOLID TUMORS
CR20180232A (en) PEPTIDE MACROCICLES AGAINST ACINETOBACTER BAUMANNII
UY35916A (en) TRICYCLIC COMPOUNDS AS BROMODOMINUM INHIBITING ANTINEOPLASTIC AGENTS
ECSP20046463A (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING DISEASES INVOLVING TISSUES WITH ACIDIC OR HYPOXIC DISEASES
ECSP088747A (en) PIRAZOLES AS INHIBITORS OF THE 11-BETA-HSD1
UY36702A (en) PIRIDINES REPLACED AND METHODS OF USE
CO2019009722A2 (en) Therapeutic dendrimers
CO2021015793A2 (en) Methods of treating or preventing asthma by administering an il-33 antagonist
CL2021001388A1 (en) Useful compounds in hiv therapy
CR20150653A (en) NEW COMPOUNDS FOR CANCER TREATMENT
DOP2019000100A (en) DERIVATIVES OF NAFTIRIDINONE AND ITS USE IN THE TREATMENT OF ARRITMIA
ECSP16086247A (en) (S) -PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE
MX2020004678A (en) Use of riluzole prodrugs to treat ataxias.
ECSP16086232A (en) (R) -PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE
PE20181450A1 (en) 1,3,4-THADIAZOLE COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER
ECSP13012988A (en) DERIVATIVES OF TIENOPIRIMIDINE (2,3-D) AND ITS USE TO TREAT ARRITMIA

Legal Events

Date Code Title Description
FB Suspension of granting procedure